Greetings from the CEO
Welcome to the latest edition of Imugene's Investor newsletter! I am very pleased to announce some big new items regarding Imugene.
First, after a worldwide tour of major investment centres, Imugene is currently raising AUD$20 million. In this issue, we will walk you through the details of the allocation of this funding, which includes the expansion of various clinical programs, as well as a substantial acquisition through a licensing agreement with Ohio State University and the Mayo Clinic.
To view Newsletter please download PDF attached:
Download this document